THE EFFECT OF INTERLEUKIN-2 ON THE RELEASE OF GONADOTROPIN AND PROLACTIN IN-VIVO AND IN-VITRO

被引:5
|
作者
UMEUCHI, M [1 ]
MAKINO, T [1 ]
ARISAWA, M [1 ]
IZUMI, S [1 ]
SAITO, S [1 ]
NOZAWA, S [1 ]
机构
[1] KEIO UNIV, SCH MED, DEPT OBSTET & GYNECOL, SHINJUKU KU, TOKYO 160, JAPAN
关键词
INTERLEUKIN-2 (IL-2); LUTEINIZING HORMONE (LH); FOLLICLE STIMULATING HORMONE (FSH); PROLACTIN (PRL); INTRAVENTRICULAR (3RD-VENTRICLE) INJECTION; DISPERSED ANTERIOR PITUITARY CELLS;
D O I
10.1507/endocrj.41.547
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
To evaluate a possible physiological role of Interleukin-2 (IL-2) in the control of Luteinizing hormone (LH), Follicle stimulating hormone (FSH) and Prolactin (PRL) release, conscious, ovariectomized (OVX) rats were given injections of IL-2 into the third ventricle. The third ventricular injection of IL-2 induced a significant decrease in plasma LH levels when compared to values in control animals (P<0.05). Plasma LH concentrations were significantly decreased within 5 min after the injection of IL-2 and remained decreased for 1 h. In contrast, injections of IL-2 had no effect on plasma FSH or PRL levels. To evaluate a possible direct action of IL-2 on LH, FSH and PRL release from the anterior pituitary gland, the cytokine was incubated with dispersed anterior pituitary cells for 4 h. IL-2 in the dose range between 10(-1) and 10(-3) unit stimulated the release of LH and FSH into the culture medium (P<0.05, P<0.025 vs, control, respectively). The release of PRL from incubated anterior pituitary cells was not affected at any dose of IL-2 tested. These results indicate that IL-2 possibly plays an inhibitory role in the control of gonadotropin secretion, via hypothalamic action, although it acts directly to stimulate the release of the gonadotropins at the level of the anterior pituitary gland.
引用
收藏
页码:547 / 551
页数:5
相关论文
共 50 条
  • [1] INHIBITION OF PROLACTIN-RELEASE IN-VITRO AND IN-VIVO BY CATECHOLAMINES
    SCHALLY, AV
    ARIMURA, A
    TAKAHARA, J
    REDDING, TW
    DUPONT, A
    [J]. FEDERATION PROCEEDINGS, 1974, 33 (03) : 237 - 237
  • [2] EFFECTS ON PROLACTIN RELEASE BY RAT PITUITARY IN-VIVO AND IN-VITRO
    LU, KH
    SHAAR, CJ
    KORTRIGH.KH
    MEITES, J
    [J]. FEDERATION PROCEEDINGS, 1972, 31 (02) : A221 - &
  • [3] EFFECT OF PERPHENAZINE ON SECRETION OF PROLACTIN IN-VIVO AND IN-VITRO
    BLACKWELL, R
    VALE, W
    RIVIER, C
    GUILLEMIN, R
    [J]. PROCEEDINGS OF THE SOCIETY FOR EXPERIMENTAL BIOLOGY AND MEDICINE, 1973, 142 (01): : 68 - 71
  • [4] NEUROPHYSIN STIMULATES PROLACTIN-RELEASE IN IN-VITRO AND IN-VIVO SYSTEMS
    SHIN, SH
    HARVEY, L
    HEISLER, R
    OBONSAWIN, M
    [J]. ANNALS OF THE NEW YORK ACADEMY OF SCIENCES, 1993, 689 : 667 - 669
  • [5] IN-VIVO AND IN-VITRO EFFECTS OF DRUGS ON PROLACTIN RELEASE BY RAT PITUITARY
    LU, KH
    KOCH, Y
    AMENOMOR.Y
    CHEN, CL
    MEITES, J
    [J]. FEDERATION PROCEEDINGS, 1970, 29 (02) : A579 - +
  • [6] STRUCTURE AND FUNCTION IN-VITRO AND IN-VIVO OF A FAMILY OF MURINE INTERLEUKIN-2/FC IMMUNOLIGANDS
    STEELE, AW
    ZHENG, XX
    STROM, TB
    [J]. CLINICAL RESEARCH, 1993, 41 (03): : A618 - A618
  • [7] IN-VITRO AND IN-VIVO CYTOGENETIC EFFECTS OF RECOMBINANT INTERLEUKIN-2 ON HUMAN-LYMPHOCYTES
    SHINKAI, T
    TAMURA, T
    SANO, T
    KOJIMA, A
    EGUCHI, K
    SASAKI, Y
    OHE, Y
    SAIJO, N
    [J]. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 1994, 17 (01): : 50 - 54
  • [8] THE EFFECT OF GHRH ON TSH RELEASE IN RATS IN-VIVO AND IN-VITRO
    LOOIJ, BJ
    KRUSEMAN, ACN
    ROELFSEMA, F
    VANDERHEIDE, D
    HOOGMA, RPLM
    SCHRODERVANDERELST, JP
    [J]. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION, 1995, 18 (03) : 214 - 219
  • [9] EFFECTS OF A SYNTHETIC PREPARATION OF GONADOTROPIN RELEASING FACTOR ON GONADOTROPIN RELEASE FROM OVINE PITUITARY IN-VITRO AND IN-VIVO
    CRIGHTON, DB
    FOSTER, JP
    [J]. JOURNAL OF ENDOCRINOLOGY, 1972, 55 (02) : R23 - R23
  • [10] EFFECT OF CHLORPROMAZINE (CPZ) ON INSULIN RELEASE IN-VIVO AND IN-VITRO IN RAT
    AMMON, HPT
    ORCI, L
    STEINKE, J
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1973, 187 (02): : 423 - 429